| __timestamp | BioCryst Pharmaceuticals, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 406114000 |
| Thursday, January 1, 2015 | 13047000 | 449119000 |
| Friday, January 1, 2016 | 11253000 | 502892000 |
| Sunday, January 1, 2017 | 13933000 | 544156000 |
| Monday, January 1, 2018 | 29514000 | 683530000 |
| Tuesday, January 1, 2019 | 37121000 | 736942000 |
| Wednesday, January 1, 2020 | 67929000 | 854233000 |
| Friday, January 1, 2021 | 118818000 | 1451683000 |
| Saturday, January 1, 2022 | 159371000 | 1416967000 |
| Sunday, January 1, 2023 | 213894000 | 1343105000 |
Cracking the code
In the competitive landscape of pharmaceuticals, Jazz Pharmaceuticals plc and BioCryst Pharmaceuticals, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Jazz Pharmaceuticals has consistently outpaced BioCryst, with SG&A expenses peaking at approximately 1.45 billion in 2021, a staggering 250% increase from 2014. In contrast, BioCryst's expenses grew from 7.5 million in 2014 to 214 million in 2023, marking a significant 2800% rise. This divergence highlights Jazz's robust market presence and strategic investments, while BioCryst's rapid growth reflects its aggressive expansion efforts. As the pharmaceutical industry evolves, these trends underscore the importance of strategic financial management in sustaining competitive advantage.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Sanofi or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Gilead Sciences, Inc. vs BioCryst Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Neurocrine Biosciences, Inc. and Jazz Pharmaceuticals plc
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and BioCryst Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Jazz Pharmaceuticals plc
Who Optimizes SG&A Costs Better? Insmed Incorporated or BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Bausch Health Companies Inc. and BioCryst Pharmaceuticals, Inc.
Mesoblast Limited and BioCryst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared